Article

Dr. Pomerance: How the mix of medicine and surgery attracted him to ophthalmology

Tennessee Academy of Ophthalmology’s doctor of the month shares what excites him about ophthalmology, his biggest career challenge, and chocolate as his favorite comfort food.

Dr. Pomerance: How the great mix of medicine and surgery attracted him to ophthalmology

Pomerance

When and why did you decide to pursue ophthalmology?

While in training for General Surgery at Walter Reed Army Medical Center, I was assigned to the Ophthalmology Department for a rotation. I was immediately attracted to ophthalmology because of the great mix of medicine and surgery. The eye is often the window to the rest of the body and ophthalmologists are often called to assist in the diagnosis of medical conditions unrelated to the eye. Often a routine exam of the eye leads us to a diagnosis that would remain otherwise obscure.

The surgical aspects of this specialty are truly dynamic and unique. During my career, there have been quantum leaps in technology and surgeon capability in ophthalmology. It continues to be exciting for me to go to work every day, since there are always new challenges and new treatments to combat vision loss.

For more of this Q&A with Dr. Pomerance, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
© 2025 MJH Life Sciences

All rights reserved.